CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Cefotetan And Dextrose In Duplex Container patents expire, and when can generic versions of Cefotetan And Dextrose In Duplex Container launch?
Cefotetan And Dextrose In Duplex Container is a drug marketed by B Braun and is included in one NDA.
The generic ingredient in CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER is cefotetan disodium. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER?
- What are the global sales for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER?
- What is Average Wholesale Price for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER?
Summary for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 36 |
| Patent Applications: | 927 |
| DailyMed Link: | CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER at DailyMed |
US Patents and Regulatory Information for CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER | cefotetan disodium | INJECTABLE;INJECTION | 065430-001 | Aug 9, 2007 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| B Braun | CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER | cefotetan disodium | INJECTABLE;INJECTION | 065430-002 | Aug 9, 2007 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
